CN Stock MarketDetailed Quotes

600557 Jiangsu Kanion Pharmaceutical

Watchlist
  • 17.57
  • +0.37+2.15%
Market Closed Jun 4 15:00 CST
10.22BMarket Cap18.81P/E (TTM)

Jiangsu Kanion Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
38.88%2.05B
22.98%1.97B
25.93%1.49B
106.54%1.98B
104.09%1.47B
70.82%1.6B
52.10%1.19B
43.71%957.36M
66.34%721.91M
21.93%937.44M
Transactional financial assets
122.77%450M
170.59%460M
162.96%710M
-19.11%182M
-31.53%202M
-3.41%170M
84.93%270M
100.89%225M
375.81%295M
3,811.11%176M
Notes receivable and accounts receivable
-2.45%695.44M
-10.22%653.77M
-14.12%660.18M
-12.58%664.32M
-11.33%712.93M
-0.52%728.22M
-8.73%768.71M
-19.41%759.91M
-21.61%804.03M
-23.37%732.06M
-Accounts receivable
-2.45%695.44M
-10.22%653.77M
-14.12%660.18M
-12.58%664.32M
-11.33%712.93M
-0.52%728.22M
-8.73%768.71M
-19.41%759.91M
-21.61%804.03M
-23.37%732.06M
Other receivables (including interest and dividends)
2.88%13.74M
-45.02%5.32M
-44.86%7.93M
-8.43%12.41M
16.68%13.35M
-17.70%9.67M
5.35%14.38M
6.16%13.55M
-18.43%11.44M
19.62%11.75M
-Other receivable
----
----
----
-8.43%12.41M
----
-17.70%9.67M
----
6.16%13.55M
----
19.62%11.75M
Advance payment
-45.61%25.43M
-52.69%28.63M
99.95%85.35M
12.79%44.43M
-35.78%46.75M
86.49%60.51M
-1.64%42.69M
-27.03%39.39M
8.51%72.8M
-38.02%32.45M
Inventories
7.42%395.82M
2.13%350.11M
52.56%361.3M
21.37%338.61M
31.85%368.47M
1.40%342.82M
-29.34%236.82M
-18.40%278.99M
-25.27%279.46M
-10.21%338.08M
Receivable financing
-34.54%537.03M
-40.44%442.23M
-45.62%310.19M
-14.66%544.79M
23.26%820.42M
20.15%742.52M
28.90%570.37M
22.61%638.41M
-8.33%665.6M
-6.43%617.98M
Assets held for sale
----
--67.04M
----
----
----
----
----
----
----
----
Other current assets
16.59%58.59M
-1.94%73.36M
124.21%1.89M
901.16%7.63M
432.27%50.25M
162.82%74.81M
-79.70%844.36K
-81.17%761.79K
-83.22%9.44M
-50.87%28.46M
Total current assets
14.50%4.22B
8.58%4.05B
17.50%3.63B
29.45%3.77B
28.95%3.69B
29.77%3.73B
18.53%3.09B
9.75%2.91B
3.64%2.86B
-0.40%2.87B
Non Current assets
Other non-current financial assets
-64.12%11.21M
-73.00%11.21M
-63.36%18.73M
-51.64%25.58M
-44.79%31.24M
-26.63%41.52M
-13.36%51.11M
-10.34%52.89M
-6.77%56.59M
-18.68%56.59M
Long-term equity investment
0.51%4.11M
0.51%4.11M
1.01%4.11M
1.01%4.11M
1.02%4.09M
1.02%4.09M
0.46%4.07M
0.46%4.07M
0.49%4.05M
0.49%4.05M
Fixed assets
----
----
----
-0.72%2.36B
----
-1.66%2.41B
----
-4.91%2.38B
----
-3.64%2.45B
Constru in process
----
----
----
1.91%134.29M
----
18.86%98.54M
----
325.12%131.76M
----
472.60%82.9M
Intangible assets
-15.12%190.31M
-14.61%197.38M
-10.13%214.47M
-18.83%216.22M
-18.33%224.2M
-18.24%231.15M
-17.74%238.66M
-18.01%266.37M
-17.43%274.52M
-17.04%282.73M
Development expenditure
3.66%172.77M
3.09%171.7M
4.86%165.96M
7.73%168.8M
9.78%166.67M
10.22%166.56M
6.98%158.27M
7.14%156.68M
6.23%151.82M
7.37%151.12M
Goodwill
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
0.00%58.99M
Long deferred expense
-20.37%13.62M
-21.01%14.4M
-8.26%15.28M
-8.76%16.06M
-10.18%17.11M
-8.92%18.23M
-20.65%16.66M
-19.91%17.6M
-17.05%19.05M
-16.43%20.02M
Deferred tax assets
236.25%50.61M
189.67%46.22M
64.89%27.46M
69.07%27.64M
-8.76%15.05M
-4.82%15.96M
-2.67%16.65M
-7.39%16.35M
-8.65%16.5M
-5.19%16.77M
Other non current assets
616.51%157.45M
156.97%55.6M
237.42%20.23M
178.91%22.86M
29.12%21.97M
4.42%21.63M
-67.45%6M
-48.51%8.2M
4.75%17.02M
2.87%20.72M
Total non current assets
4.19%3.16B
0.05%3.07B
0.05%3.06B
-1.80%3.03B
-3.03%3.03B
-2.48%3.07B
-2.54%3.06B
-2.81%3.09B
-2.56%3.13B
-2.75%3.14B
Total assets
9.85%7.38B
4.73%7.12B
8.81%6.7B
13.37%6.8B
12.25%6.72B
12.92%6.8B
7.01%6.15B
2.91%6B
0.31%5.98B
-1.64%6.02B
Liabilities
Current liabilities
Short term loan
----
----
----
----
----
----
--0
----
-67.88%110M
-51.95%234.5M
Notes payable and accounts payable
-14.79%253.75M
-38.82%228.42M
-35.42%204.24M
-22.17%230.34M
6.10%297.81M
3.79%373.36M
-3.82%316.24M
-0.05%295.97M
-21.42%280.7M
28.02%359.75M
-Notes payable
----
----
----
-52.70%7.5M
-49.36%11.27M
-69.73%11.86M
-59.34%17.94M
-42.75%15.85M
-51.65%22.25M
0.29%39.18M
-Accounts payable
-11.44%253.75M
-36.81%228.42M
-31.53%204.24M
-20.45%222.84M
10.87%286.54M
12.77%361.5M
4.78%298.31M
4.35%280.11M
-16.95%258.44M
32.50%320.56M
Contract liabilities
-65.65%16.1M
-88.29%25.17M
-33.31%13.84M
29.67%29.31M
188.94%46.87M
748.11%214.87M
49.70%20.75M
8.90%22.61M
-32.58%16.22M
-4.40%25.34M
Salaries payable
-60.74%8M
-34.04%25.73M
28.50%32.8M
29.47%25.84M
64.52%20.38M
60.22%39M
36.80%25.53M
39.86%19.95M
15.44%12.39M
-3.37%24.34M
Taxs payable
106.35%59.58M
-23.56%70.67M
8.36%70.8M
-11.40%68.04M
-23.76%28.87M
84.04%92.44M
28.88%65.34M
202.13%76.79M
192.08%37.87M
78.58%50.23M
Other payable (including interest and dividends)
18.37%1.37B
19.88%1.24B
26.82%1.11B
55.27%1.26B
36.46%1.16B
36.81%1.03B
34.73%872.98M
11.55%809.75M
10.72%851.03M
-10.47%755.41M
-Dividend payable
----
----
----
--128.61M
----
----
----
----
----
----
-Other payable
----
----
----
39.39%1.13B
----
36.81%1.03B
----
11.55%809.75M
----
-10.47%755.41M
Hold and for sell liabilities
----
--16.55M
----
----
----
----
----
----
----
----
Other current liabilities
-65.77%2.09M
-88.34%3.26M
-33.58%1.79M
29.18%3.8M
188.94%6.09M
748.11%27.93M
49.70%2.7M
8.90%2.94M
-32.58%2.11M
-4.40%3.29M
Total current liabilities
9.79%1.71B
-9.68%1.61B
9.75%1.43B
31.48%1.61B
19.16%1.56B
22.59%1.78B
0.56%1.3B
-11.63%1.23B
-13.75%1.31B
-14.34%1.45B
Current liabilities
Long term account payable
----
----
----
--0
----
--0
----
--0
----
--0
Specific account payable
----
----
----
0.00%1.93M
----
0.00%1.93M
----
0.00%1.93M
----
0.00%1.93M
Long term deferred income
98.08%154.57M
60.14%126.16M
-12.49%76.62M
-11.06%77.97M
-12.94%78.03M
-12.97%78.78M
-3.69%87.55M
-4.55%87.66M
-3.54%89.63M
-3.51%90.52M
Total non current liabilities
95.72%156.5M
58.70%128.08M
-12.22%78.54M
-10.83%79.89M
-12.67%79.96M
-12.70%80.71M
-3.62%89.48M
-4.46%89.59M
-3.64%91.56M
-3.44%92.44M
Total liabilities
13.97%1.87B
-6.72%1.74B
8.34%1.51B
28.61%1.69B
17.08%1.64B
20.48%1.86B
0.28%1.39B
-11.18%1.32B
-13.16%1.4B
-13.76%1.55B
Shareholders equity
Paid-in capital
0.03%584.75M
0.03%584.75M
0.00%584.6M
1.42%584.6M
1.42%584.6M
-1.40%584.6M
-1.40%584.6M
-2.77%576.43M
-2.77%576.43M
0.00%592.88M
Capital reserve funds
13.92%111.79M
13.92%111.79M
47.47%122.07M
365.07%122.07M
273.86%98.13M
-42.88%98.13M
-52.58%82.78M
-84.96%26.25M
-84.96%26.25M
-1.59%171.79M
Surplus reserve funds
0.00%292.81M
0.00%292.81M
0.00%292.81M
0.00%292.81M
0.00%292.81M
-5.79%292.81M
-5.79%292.81M
-5.79%292.81M
-5.79%292.81M
0.00%310.82M
Retained profit
10.41%4.4B
10.62%4.25B
10.14%4.06B
10.23%3.99B
13.24%3.98B
12.75%3.84B
11.98%3.69B
11.46%3.62B
10.92%3.52B
10.38%3.41B
Less:Treasury stock
-3.78%62.26M
-25.60%48.14M
0.00%64.7M
--64.7M
--64.7M
-64.06%64.7M
-64.06%64.7M
----
----
--180M
Shareholders equity without minority interests
8.81%5.33B
9.23%5.19B
9.01%5B
9.07%4.93B
10.90%4.9B
10.45%4.75B
9.34%4.59B
7.86%4.52B
5.34%4.41B
3.31%4.3B
Minority interests
0.75%182.64M
4.43%187.76M
7.25%187.67M
9.50%184.61M
7.43%181.27M
6.80%179.8M
4.52%174.98M
3.91%168.59M
4.40%168.74M
5.13%168.35M
Total shareholder equity
8.52%5.51B
9.05%5.38B
8.95%5.19B
9.09%5.11B
10.77%5.08B
10.31%4.93B
9.16%4.76B
7.71%4.68B
5.30%4.58B
3.37%4.47B
Total liabilityies and equity
9.85%7.38B
4.73%7.12B
8.81%6.7B
13.37%6.8B
12.25%6.72B
12.92%6.8B
7.01%6.15B
2.91%6B
0.31%5.98B
-1.64%6.02B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 38.88%2.05B22.98%1.97B25.93%1.49B106.54%1.98B104.09%1.47B70.82%1.6B52.10%1.19B43.71%957.36M66.34%721.91M21.93%937.44M
Transactional financial assets 122.77%450M170.59%460M162.96%710M-19.11%182M-31.53%202M-3.41%170M84.93%270M100.89%225M375.81%295M3,811.11%176M
Notes receivable and accounts receivable -2.45%695.44M-10.22%653.77M-14.12%660.18M-12.58%664.32M-11.33%712.93M-0.52%728.22M-8.73%768.71M-19.41%759.91M-21.61%804.03M-23.37%732.06M
-Accounts receivable -2.45%695.44M-10.22%653.77M-14.12%660.18M-12.58%664.32M-11.33%712.93M-0.52%728.22M-8.73%768.71M-19.41%759.91M-21.61%804.03M-23.37%732.06M
Other receivables (including interest and dividends) 2.88%13.74M-45.02%5.32M-44.86%7.93M-8.43%12.41M16.68%13.35M-17.70%9.67M5.35%14.38M6.16%13.55M-18.43%11.44M19.62%11.75M
-Other receivable -------------8.43%12.41M-----17.70%9.67M----6.16%13.55M----19.62%11.75M
Advance payment -45.61%25.43M-52.69%28.63M99.95%85.35M12.79%44.43M-35.78%46.75M86.49%60.51M-1.64%42.69M-27.03%39.39M8.51%72.8M-38.02%32.45M
Inventories 7.42%395.82M2.13%350.11M52.56%361.3M21.37%338.61M31.85%368.47M1.40%342.82M-29.34%236.82M-18.40%278.99M-25.27%279.46M-10.21%338.08M
Receivable financing -34.54%537.03M-40.44%442.23M-45.62%310.19M-14.66%544.79M23.26%820.42M20.15%742.52M28.90%570.37M22.61%638.41M-8.33%665.6M-6.43%617.98M
Assets held for sale ------67.04M--------------------------------
Other current assets 16.59%58.59M-1.94%73.36M124.21%1.89M901.16%7.63M432.27%50.25M162.82%74.81M-79.70%844.36K-81.17%761.79K-83.22%9.44M-50.87%28.46M
Total current assets 14.50%4.22B8.58%4.05B17.50%3.63B29.45%3.77B28.95%3.69B29.77%3.73B18.53%3.09B9.75%2.91B3.64%2.86B-0.40%2.87B
Non Current assets
Other non-current financial assets -64.12%11.21M-73.00%11.21M-63.36%18.73M-51.64%25.58M-44.79%31.24M-26.63%41.52M-13.36%51.11M-10.34%52.89M-6.77%56.59M-18.68%56.59M
Long-term equity investment 0.51%4.11M0.51%4.11M1.01%4.11M1.01%4.11M1.02%4.09M1.02%4.09M0.46%4.07M0.46%4.07M0.49%4.05M0.49%4.05M
Fixed assets -------------0.72%2.36B-----1.66%2.41B-----4.91%2.38B-----3.64%2.45B
Constru in process ------------1.91%134.29M----18.86%98.54M----325.12%131.76M----472.60%82.9M
Intangible assets -15.12%190.31M-14.61%197.38M-10.13%214.47M-18.83%216.22M-18.33%224.2M-18.24%231.15M-17.74%238.66M-18.01%266.37M-17.43%274.52M-17.04%282.73M
Development expenditure 3.66%172.77M3.09%171.7M4.86%165.96M7.73%168.8M9.78%166.67M10.22%166.56M6.98%158.27M7.14%156.68M6.23%151.82M7.37%151.12M
Goodwill 0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M0.00%58.99M
Long deferred expense -20.37%13.62M-21.01%14.4M-8.26%15.28M-8.76%16.06M-10.18%17.11M-8.92%18.23M-20.65%16.66M-19.91%17.6M-17.05%19.05M-16.43%20.02M
Deferred tax assets 236.25%50.61M189.67%46.22M64.89%27.46M69.07%27.64M-8.76%15.05M-4.82%15.96M-2.67%16.65M-7.39%16.35M-8.65%16.5M-5.19%16.77M
Other non current assets 616.51%157.45M156.97%55.6M237.42%20.23M178.91%22.86M29.12%21.97M4.42%21.63M-67.45%6M-48.51%8.2M4.75%17.02M2.87%20.72M
Total non current assets 4.19%3.16B0.05%3.07B0.05%3.06B-1.80%3.03B-3.03%3.03B-2.48%3.07B-2.54%3.06B-2.81%3.09B-2.56%3.13B-2.75%3.14B
Total assets 9.85%7.38B4.73%7.12B8.81%6.7B13.37%6.8B12.25%6.72B12.92%6.8B7.01%6.15B2.91%6B0.31%5.98B-1.64%6.02B
Liabilities
Current liabilities
Short term loan --------------------------0-----67.88%110M-51.95%234.5M
Notes payable and accounts payable -14.79%253.75M-38.82%228.42M-35.42%204.24M-22.17%230.34M6.10%297.81M3.79%373.36M-3.82%316.24M-0.05%295.97M-21.42%280.7M28.02%359.75M
-Notes payable -------------52.70%7.5M-49.36%11.27M-69.73%11.86M-59.34%17.94M-42.75%15.85M-51.65%22.25M0.29%39.18M
-Accounts payable -11.44%253.75M-36.81%228.42M-31.53%204.24M-20.45%222.84M10.87%286.54M12.77%361.5M4.78%298.31M4.35%280.11M-16.95%258.44M32.50%320.56M
Contract liabilities -65.65%16.1M-88.29%25.17M-33.31%13.84M29.67%29.31M188.94%46.87M748.11%214.87M49.70%20.75M8.90%22.61M-32.58%16.22M-4.40%25.34M
Salaries payable -60.74%8M-34.04%25.73M28.50%32.8M29.47%25.84M64.52%20.38M60.22%39M36.80%25.53M39.86%19.95M15.44%12.39M-3.37%24.34M
Taxs payable 106.35%59.58M-23.56%70.67M8.36%70.8M-11.40%68.04M-23.76%28.87M84.04%92.44M28.88%65.34M202.13%76.79M192.08%37.87M78.58%50.23M
Other payable (including interest and dividends) 18.37%1.37B19.88%1.24B26.82%1.11B55.27%1.26B36.46%1.16B36.81%1.03B34.73%872.98M11.55%809.75M10.72%851.03M-10.47%755.41M
-Dividend payable --------------128.61M------------------------
-Other payable ------------39.39%1.13B----36.81%1.03B----11.55%809.75M-----10.47%755.41M
Hold and for sell liabilities ------16.55M--------------------------------
Other current liabilities -65.77%2.09M-88.34%3.26M-33.58%1.79M29.18%3.8M188.94%6.09M748.11%27.93M49.70%2.7M8.90%2.94M-32.58%2.11M-4.40%3.29M
Total current liabilities 9.79%1.71B-9.68%1.61B9.75%1.43B31.48%1.61B19.16%1.56B22.59%1.78B0.56%1.3B-11.63%1.23B-13.75%1.31B-14.34%1.45B
Current liabilities
Long term account payable --------------0------0------0------0
Specific account payable ------------0.00%1.93M----0.00%1.93M----0.00%1.93M----0.00%1.93M
Long term deferred income 98.08%154.57M60.14%126.16M-12.49%76.62M-11.06%77.97M-12.94%78.03M-12.97%78.78M-3.69%87.55M-4.55%87.66M-3.54%89.63M-3.51%90.52M
Total non current liabilities 95.72%156.5M58.70%128.08M-12.22%78.54M-10.83%79.89M-12.67%79.96M-12.70%80.71M-3.62%89.48M-4.46%89.59M-3.64%91.56M-3.44%92.44M
Total liabilities 13.97%1.87B-6.72%1.74B8.34%1.51B28.61%1.69B17.08%1.64B20.48%1.86B0.28%1.39B-11.18%1.32B-13.16%1.4B-13.76%1.55B
Shareholders equity
Paid-in capital 0.03%584.75M0.03%584.75M0.00%584.6M1.42%584.6M1.42%584.6M-1.40%584.6M-1.40%584.6M-2.77%576.43M-2.77%576.43M0.00%592.88M
Capital reserve funds 13.92%111.79M13.92%111.79M47.47%122.07M365.07%122.07M273.86%98.13M-42.88%98.13M-52.58%82.78M-84.96%26.25M-84.96%26.25M-1.59%171.79M
Surplus reserve funds 0.00%292.81M0.00%292.81M0.00%292.81M0.00%292.81M0.00%292.81M-5.79%292.81M-5.79%292.81M-5.79%292.81M-5.79%292.81M0.00%310.82M
Retained profit 10.41%4.4B10.62%4.25B10.14%4.06B10.23%3.99B13.24%3.98B12.75%3.84B11.98%3.69B11.46%3.62B10.92%3.52B10.38%3.41B
Less:Treasury stock -3.78%62.26M-25.60%48.14M0.00%64.7M--64.7M--64.7M-64.06%64.7M-64.06%64.7M----------180M
Shareholders equity without minority interests 8.81%5.33B9.23%5.19B9.01%5B9.07%4.93B10.90%4.9B10.45%4.75B9.34%4.59B7.86%4.52B5.34%4.41B3.31%4.3B
Minority interests 0.75%182.64M4.43%187.76M7.25%187.67M9.50%184.61M7.43%181.27M6.80%179.8M4.52%174.98M3.91%168.59M4.40%168.74M5.13%168.35M
Total shareholder equity 8.52%5.51B9.05%5.38B8.95%5.19B9.09%5.11B10.77%5.08B10.31%4.93B9.16%4.76B7.71%4.68B5.30%4.58B3.37%4.47B
Total liabilityies and equity 9.85%7.38B4.73%7.12B8.81%6.7B13.37%6.8B12.25%6.72B12.92%6.8B7.01%6.15B2.91%6B0.31%5.98B-1.64%6.02B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg